Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06221709

Continuous Radiofrequency in Hip Osteoarthritis Pain: A Randomized Clinical Trial Comparing Radiofrequency and Corticosteroid Injection

Led by University of Brasilia · Updated on 2024-01-24

70

Participants Needed

1

Research Sites

34 weeks

Total Duration

On this page

Sponsors

U

University of Brasilia

Lead Sponsor

S

Sarah Network of Rehabilitation Hospitals

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating treatments for adults with symptomatic unilateral hip osteoarthritis, focusing on managing pain and improving function. This prospective, single-center, double-blinded, randomized clinical trial compares the effects of intraarticular corticosteroid injection alone versus combined with Conventional Radiofrequency (CRF) targeting the anterior sensory branches of the hip. The study aims to determine which approach better controls pain and enhances quality of life over 24 weeks. Participants will be randomly assigned to one of two groups. The control group receives an intraarticular injection of corticosteroid and anesthetic directly into the hip joint. The intervention group undergoes radiofrequency ablation targeting specific sensory nerves of the hip followed by the same corticosteroid and anesthetic injection as the control group. Procedures are done under sedation or general anesthesia with precise imaging guidance to ensure accurate treatment delivery. Throughout the study, participants will be assessed at baseline, 1 week, 12 weeks, and 24 weeks for pain levels, hip muscle strength, medication use, and overall satisfaction. Imaging and motor stimulation techniques ensure safety during nerve ablation. The main outcome measured is quality of life using the WOMAC questionnaire. Researchers will also monitor adverse effects. The total study duration for each participant is about 24 weeks.

CONDITIONS

Brief Title

Continuous Radiofrequency in Hip Osteoarthritis Pain: A Randomized Clinical Trial.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals 18 years of age or older
  • Symptomatic unilateral hip osteoarthritis, grades II and III by Kellgreen and Lawrance classification
  • Hip pain present for more than six months in medial, anterior, anterolateral, or lateral regions
Not Eligible

You will not qualify if you...

  • Radiculopathy with ipsilateral radiation
  • Osteonecrosis of the femoral head
  • Previous hip arthroplasty or surgical scars altering hip anatomy
  • High dislocation of the hip
  • Pain only in the posterior hip region
  • Symptomatic osteoarthritis of the ipsilateral knee
  • Corticosteroid or hyaluronic acid injection in the hip within the last six months
  • Neurological or psychiatric diseases
  • Peripheral neuropathy
  • Use of a pacemaker
  • Prothrombin activity time (INR) greater than 3

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Single treatment visit with follow-up up to 24 weeks

Participants receive either radiofrequency ablation targeting hip sensory nerves followed by intraarticular infiltration of corticosteroid and anesthetic or intraarticular infiltration alone to manage hip osteoarthritis pain.

1 treatment visit and follow-up visits at 1 week, 12 weeks, and 24 weeks

Follow-up

Duration - 24 weeks ± 1 week

Participants are monitored for changes in pain, muscle strength, medication intake, satisfaction, and any adverse effects after treatment.

Visits at 1 week, 12 weeks, and 24 weeks post-treatment

Trial Site Locations

Total: 1 location

1

Rede Sarah Hospitais de Reabilitação

Brasília, Federal District, Brazil, 70335901

Actively Recruiting

Loading map...

Research Team

G

Gilvan F Vaz, MD

J

João M Montecchi, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Adapting Rehabilitation Delivery for Maximum Impact at Home-...

Knee Osteoarthritis

Actively Recruiting

1 location

Clinical and Functional Outcome of the MobileLink Acetabular...

Osteoarthritis, Hip

Actively Recruiting

2 locations

Randomized, Prospective and Multicenter Clinical Study for t...

Radius; Deformity

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Clinically important improvement thresholds for Harris Hip Score and its ability to predict revision risk after primary total hip arthroplasty.

Jasvinder A Singh, Cathy Schleck, Scott Harmsen...

https://pubmed.ncbi.nlm.nih.gov/27286675

Pulsed radiofrequency of suprascapular nerve for chronic shoulder pain: a randomized double-blind active placebo-controlled study.

Michael Gofeld, Carlos E Restrepo-Garces, Brian R Theodore...

https://pubmed.ncbi.nlm.nih.gov/22554345

Percutaneous radiofrequency lesioning of sensory branches of the obturator and femoral nerves for the treatment of hip joint pain.

M Kawaguchi, K Hashizume, T Iwata...

https://pubmed.ncbi.nlm.nih.gov/11707799